Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer
Purpose: We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival. Patients and Methods: In all, 559 patients with pancreatic cancer from prospective biomarker studies from Denmark (n = 448) and Germany (n = 111) were studied. Plasma YKL-4...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
June 26, 2013
|
| In: |
PLOS ONE
Year: 2013, Volume: 8, Issue: 6, Pages: 1-9 |
| ISSN: | 1932-6203 |
| DOI: | 10.1371/journal.pone.0067059 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0067059 Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067059 
|
| Author Notes: | Nicolai A. Schultz, Ib J. Christensen, Jens Werner, Nathalia Giese, Benny V. Jensen, Ole Larsen, Jon K. Bjerregaard, Per Pfeiffer, Dan Calatayud, Svend E. Nielsen, Mette K. Yilmaz, Niels H. Holländer, Morten Wøjdemann, Stig E. Bojesen, Kaspar R. Nielsen, Julia S. Johansen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1764349784 | ||
| 003 | DE-627 | ||
| 005 | 20220820023038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210726s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0067059 |2 doi | |
| 035 | |a (DE-627)1764349784 | ||
| 035 | |a (DE-599)KXP1764349784 | ||
| 035 | |a (OCoLC)1341419873 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schultz, Nicolai A. |e VerfasserIn |0 (DE-588)115688389X |0 (DE-627)1019846585 |0 (DE-576)502488441 |4 aut | |
| 245 | 1 | 0 | |a Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer |c Nicolai A. Schultz, Ib J. Christensen, Jens Werner, Nathalia Giese, Benny V. Jensen, Ole Larsen, Jon K. Bjerregaard, Per Pfeiffer, Dan Calatayud, Svend E. Nielsen, Mette K. Yilmaz, Niels H. Holländer, Morten Wøjdemann, Stig E. Bojesen, Kaspar R. Nielsen, Julia S. Johansen |
| 264 | 1 | |c June 26, 2013 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.07.2021 | ||
| 520 | |a Purpose: We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival. Patients and Methods: In all, 559 patients with pancreatic cancer from prospective biomarker studies from Denmark (n = 448) and Germany (n = 111) were studied. Plasma YKL-40 and IL-6 were determined by ELISAs and serum CA 19.9 by chemiluminescent immunometric assay. Results: Odds ratios (ORs) for prediction of pancreatic cancer were significant for all biomarkers, with CA 19.9 having the highest AUC (CA 19.9: OR = 2.28, 95% CI 1.97 to 2.68, p<0.0001, AUC = 0.94; YKL-40: OR = 4.50, 3.99 to 5.08, p<0.0001, AUC = 0.87; IL-6: OR = 3.68, 3.08 to 4.44, p<0.0001, AUC = 0.87). Multivariate Cox analysis (YKL-40, IL-6, CA 19.9, age, stage, gender) in patients operated on showed that high preoperative IL-6 and CA 19.9 (dichotomized according to normal values) were independently associated with short overall survival (CA 19.9: HR = 2.51, 1.22-5.15, p = 0.013; IL-6: HR = 2.03, 1.11 to 3.70, p = 0.021). Multivariate Cox analysis of non-operable patients (Stage IIB-IV) showed that high pre-treatment levels of each biomarker were independently associated with short overall survival (YKL-40: HR = 1.30, 1.03 to 1.64, p = 0.029; IL-6: HR = 1.71, 1.33 to 2.20, p<0.0001; CA 19.9: HR = 1.54, 1.06 to 2.24, p = 0.022). Patients with preoperative elevation of both IL-6 and CA 19.9 had shorter overall survival (p<0.005) compared to patients with normal levels of both biomarkers (45% vs. 92% alive after 12 months). Conclusions: Plasma YKL-40 and IL-6 had less diagnostic impact than CA 19.9. Combination of pretreatment YKL-40, IL-6, and CA 19.9 may have clinical value to identify pancreatic cancer patients with the poorest prognosis. | ||
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Blood plasma | |
| 650 | 4 | |a Cancer detection and diagnosis | |
| 650 | 4 | |a Cancer treatment | |
| 650 | 4 | |a Diagnostic medicine | |
| 650 | 4 | |a Gastrointestinal cancers | |
| 650 | 4 | |a Pancreatic cancer | |
| 650 | 4 | |a Surgical and invasive medical procedures | |
| 700 | 1 | |a Christensen, Ib J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Werner, Jens |d 1966- |e VerfasserIn |0 (DE-588)120690764 |0 (DE-627)704926717 |0 (DE-576)292340249 |4 aut | |
| 700 | 1 | |a Giese, Nathalia |e VerfasserIn |0 (DE-588)1033180955 |0 (DE-627)740120018 |0 (DE-576)380769123 |4 aut | |
| 700 | 1 | |a Jensen, Benny V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Larsen, Ole |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bjerregaard, Jon K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfeiffer, Per |e VerfasserIn |4 aut | |
| 700 | 1 | |a Calatayud, Dan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nielsen, Svend E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yilmaz, Mette K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holländer, Niels H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wøjdemann, Morten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bojesen, Stig E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nielsen, Kaspar R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Johansen, Julia S. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLOS ONE |d San Francisco, California, US : PLOS, 2006 |g 8(2013), 6, Artikel-ID e67059, Seite 1-9 |h Online-Ressource |w (DE-627)523574592 |w (DE-600)2267670-3 |w (DE-576)281331979 |x 1932-6203 |7 nnas |a Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer |
| 773 | 1 | 8 | |g volume:8 |g year:2013 |g number:6 |g elocationid:e67059 |g pages:1-9 |g extent:9 |a Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0067059 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067059 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210726 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1033180955 |a Giese, Nathalia |m 1033180955:Giese, Nathalia |d 910000 |d 910200 |e 910000PG1033180955 |e 910200PG1033180955 |k 0/910000/ |k 1/910000/910200/ |p 4 | ||
| 998 | |g 120690764 |a Werner, Jens |m 120690764:Werner, Jens |d 910000 |d 910200 |e 910000PW120690764 |e 910200PW120690764 |k 0/910000/ |k 1/910000/910200/ |p 3 | ||
| 999 | |a KXP-PPN1764349784 |e 3957589738 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 26.07.2021"],"language":["eng"],"person":[{"role":"aut","family":"Schultz","display":"Schultz, Nicolai A.","given":"Nicolai A."},{"display":"Christensen, Ib J.","family":"Christensen","role":"aut","given":"Ib J."},{"display":"Werner, Jens","family":"Werner","role":"aut","given":"Jens"},{"given":"Nathalia","display":"Giese, Nathalia","role":"aut","family":"Giese"},{"role":"aut","family":"Jensen","display":"Jensen, Benny V.","given":"Benny V."},{"display":"Larsen, Ole","family":"Larsen","role":"aut","given":"Ole"},{"given":"Jon K.","family":"Bjerregaard","role":"aut","display":"Bjerregaard, Jon K."},{"given":"Per","display":"Pfeiffer, Per","family":"Pfeiffer","role":"aut"},{"given":"Dan","role":"aut","family":"Calatayud","display":"Calatayud, Dan"},{"role":"aut","family":"Nielsen","display":"Nielsen, Svend E.","given":"Svend E."},{"role":"aut","family":"Yilmaz","display":"Yilmaz, Mette K.","given":"Mette K."},{"display":"Holländer, Niels H.","role":"aut","family":"Holländer","given":"Niels H."},{"display":"Wøjdemann, Morten","family":"Wøjdemann","role":"aut","given":"Morten"},{"display":"Bojesen, Stig E.","family":"Bojesen","role":"aut","given":"Stig E."},{"given":"Kaspar R.","family":"Nielsen","role":"aut","display":"Nielsen, Kaspar R."},{"role":"aut","family":"Johansen","display":"Johansen, Julia S.","given":"Julia S."}],"recId":"1764349784","id":{"eki":["1764349784"],"doi":["10.1371/journal.pone.0067059"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"June 26, 2013","dateIssuedKey":"2013"}],"name":{"displayForm":["Nicolai A. Schultz, Ib J. Christensen, Jens Werner, Nathalia Giese, Benny V. Jensen, Ole Larsen, Jon K. Bjerregaard, Per Pfeiffer, Dan Calatayud, Svend E. Nielsen, Mette K. Yilmaz, Niels H. Holländer, Morten Wøjdemann, Stig E. Bojesen, Kaspar R. Nielsen, Julia S. Johansen"]},"relHost":[{"title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"pubHistory":["1.2006 -"],"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"disp":"Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancerPLOS ONE","corporate":[{"display":"Public Library of Science","role":"isb"}],"origin":[{"dateIssuedDisp":"2006-","publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedKey":"2006","publisher":"PLOS ; PLoS"}],"id":{"zdb":["2267670-3"],"eki":["523574592"],"issn":["1932-6203"]},"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"8","text":"8(2013), 6, Artikel-ID e67059, Seite 1-9","extent":"9","issue":"6","year":"2013","pages":"1-9"},"language":["eng"],"name":{"displayForm":["Public Library of Science"]},"recId":"523574592","type":{"bibl":"periodical","media":"Online-Ressource"}}],"physDesc":[{"extent":"9 S."}],"title":[{"title":"Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer","title_sort":"Diagnostic and prognostic impact of circulating YKL-40, IL-6, and CA 19.9 in patients with pancreatic cancer"}]} | ||
| SRT | |a SCHULTZNICDIAGNOSTIC2620 | ||